| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |